232 filings
Page 7 of 12
8-K
n3oossrmcjs2h6x
14 Dec 18
Departure of Directors or Certain Officers
4:30pm
8-K
rnyzd0 mw9u
13 Nov 18
Departure of Directors or Certain Officers
5:00pm
8-K
6edfvn7sm80lop6
19 Oct 18
Departure of Directors or Certain Officers
4:31pm
8-K
wqvqg6l4ycp
18 Oct 18
Departure of Directors or Certain Officers
4:31pm
8-K
c9ixoxejdi968i12x
3 Oct 18
Departure of Directors or Certain Officers
4:31pm
8-K
hm15i9yx 6ngq0u
18 Sep 18
ContraVir Pharmaceuticals Announces Completion of Phase 1 with CRV431
12:00am
8-K
g9ym03pw8v5
5 Sep 18
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
8-K
wtegy8
27 Aug 18
Other Events
12:00am
8-K
fejzkxhn193pigrhn
6 Aug 18
ContraVir Pharmaceuticals Provides an Update to Corporate Objectives
5:27pm
8-K
smv6ti
23 Jul 18
ContraVir Pharmaceuticals Reports Progress in Phase 1/2A Trial of CRV431
12:37pm
8-K
kr4 bp2imo
5 Jul 18
Material Modifications to Rights of Security Holders
4:03pm
8-K
ytkoy
25 Jun 18
Other Events
11:24am
8-K
zhzty
21 Jun 18
Other Events
7:58am
8-K
1y5 lj4dxexq4
19 Jun 18
ContraVir Pharmaceuticals to Provide Corporate, Business and Clinical Updates
12:00am
8-K
66tlmz6
14 Jun 18
ContraVir Pharmaceuticals Announces the Approval of the IND and Initiation of the Clinical Development Program of CRV431 in the United States
12:00am
8-K
nxpe ufb0qhlr8w
13 Jun 18
ContraVir Pharmaceuticals Reminds Investors of Today’s Deadline to be a Shareholder of Record
12:00am
8-K
rlaiv9
6 Jun 18
ContraVir Pharmaceuticals Informs Stockholders of Key Dates and Terms Related to Announced Rights Offering
6:01am
8-K
r9he3kkpjx
31 May 18
Other Events
8:21am
8-K
bk4rp4e36lk5p5
30 May 18
Other Events
10:20am
8-K
d1aafnk
29 May 18
ContraVir Pharmaceuticals to Present at 2018 BIO International Convention
4:29pm